ABSTRACT Aim: We explored whether placental histology could help to diagnose early-onset neonatal sepsis (EONS), guide clinical decision-making 48 hours after birth and reduce antibiotic use.
INTRODUCTION
Although the incidence of proven early-onset neonatal sepsis (EONS) is low, at 0.8-1.0 per 1000, most infants born at less than 32 weeks gestation receive broad-spectrum antibiotics during the first days of life because of suspected EONS (1, 2) . Suspected EONS is mainly based on maternal risk factors and non-specific neonatal clinical symptoms, such as respiratory failure, circulatory shock, temperature instability, lethargy, jaundice or a low Apgar score. Starting timely appropriate antibiotic treatment is extremely important because EONS has a high risk of morbidity and mortality (2) (3) (4) . In the absence of a gold standard to confirm EONS, the number of infants that require treatment is high: for one infant with proven EONS, 30 infants are treated with antibiotics (5) (6) (7) (8) .
Antibiotic use has many disadvantages, especially if used for a prolonged duration, and antibiotic resistance is becoming a huge problem worldwide. It has been reported that antibiotics affect the development of the microbiome, which increases the risk of necrotising enterocolitis (NEC) and late-onset neonatal sepsis in the neonatal period and obesity and asthma later in life (9) (10) (11) . Therefore, when medical decisions are made about the duration of antibiotic therapy in premature infants, it is very important to make sure the treatment is as short and narrow as possible (12, 13) . Generally, antibiotic therapy is started soon after birth and then evaluated after 48 hours, based on a combination of diagnostic results, namely blood culture, serial C-reactive protein (CRP) values and clinical symptoms, despite their Abbreviations CRP, C-reactive protein; EONS, Early-onset neonatal sepsis; HELPP, Haemolysis Elevated Liver enzymes and Low Platelets; IUGR, Intra-uterine growth retardation; NEC, Necrotising enterocolitis; NICU, Neonatal intensive care unit; PROM, Premature rupture of membranes.
Key notes
This study evaluated the role of placenta histology in diagnosing early-onset neonatal sepsis (EONS) in 88 premature infants. Histological responses were more likely if there was a high suspicion of EONS, did not occur in the absence of maternal risk factors. Placental histology reduced the duration of antibiotic therapy in 20/27 (74%) infants. Placental histology could be an additional tool to diagnose EONS and reduce antibiotic use.
limited positive predictive value. Blood cultures can be false negative as a result of the maternal use of antibiotics before labour or due to a small blood volume of less than 1 mL (14, 15) . Serial CRP values have an excellent negative predictive value, but limited positive predictive value, and clinical symptoms are often non-specific (6) . Consequently, most infants with non-specific clinical symptoms and serial CRP levels >10 mg/L are treated with antibiotics for more than 48 hours, often seven days, despite a negative blood culture. In these cases, an additional diagnostic tool for excluding EONS is important and has the potential to reduce the duration of antibiotic therapy. Previous studies have shown a significant relationship between EONS and a histological inflammatory response of the placenta. Funisitis is suggested to be the hallmark of foetal infection. The relative risk for EONS in the presence of chorioamnionitis is 10 and the risk for funisitis is seven (16) (17) (18) (19) . Furthermore, Lee et al. described a negative predictive value of 100% for EONS in the absence of chorioamnionitis (17) .
We hypothesised that placental histology would be of clinical value as an additional tool in diagnosing EONS and would facilitate medical decision-making 48 hours postpartum, reducing the duration of antibiotic treatment and therefore antibiotic use in the neonatal intensive care unit (NICU).
METHODS

Study population
A single-centre, retrospective association study was performed at our level three NICU at Isala, Zwolle, The Netherlands. The cohort comprised all 109 premature singletons with a gestational age 24 + 0 to 31 + 6 weeks who were admitted between January 2013 and December 2013. We excluded 20 neonates because they were not born in the hospital, there was an absence of placental material, they died within 48 hours or had major congenital malformations. In addition, one infant was excluded because of a proven maternal and neonatal Chlamydia infection, leaving 88 in the study (Fig. 1) . The study was approved by the hospital's Medical Ethical Committee.
Clinical data collection
The following neonatal data were collected from hospital records: gestational age, birth weight, gender, duration of antibiotic treatment, mortality, serial CRP at days zero, one and two and blood cultures. The maternal clinical data that were recorded were: age, parity, rectal temperature, foetal and maternal heart rate, premature rupture of the membranes (PROM), antibiotic treatment during labour, preeclampsia or haemolysis elevated liver enzymes and low platelets (HELLP) syndrome, intra-uterine growth retardation (IUGR), delivery mode and antenatal use of corticosteroids. Laboratory data were also collected on the mother, namely CRP, a white blood-cell count at less than 24 hours antepartum and blood and vaginal cultures.
Diagnosis of early-onset neonatal sepsis
Proven EONS was defined as presenting with the clinical symptoms of EONS combined with a positive blood culture and raised serial CRP level >10 (mg/L) within 48-72 hours postpartum. Suspected EONS was defined as having clinical symptoms and a raised serial CRP level >10 (mg/L), but a negative blood culture. In cases of suspected EONS, the groups were defined by serial CRP levels of either up to or more than 10 (mg/L) and the clinical presence of maternal symptoms of intra-uterine infection. These were defined as a maternal temperature of at ≥37.8°C, maternal tachycardia (>100/min), foetal tachycardia (>160/min), tenderness of the uterus, foul-smelling amniotic fluid and leucocytosis (>15 000 cells/mm 3 ) or other risk factors for EONS, PROM or preterm onset of labour. A total of four groups were defined: (i) proven EONS, (ii) no suspicion of EONS with a CRP ≤ 10 (mg/L), (iii) low suspicion of EONS with raised CRP levels >10 (mg/L) and the absence of risk factors for EONS and (iv) high suspicion, with raised CRP levels >10 (mg/L) and the presence of risk factors for EONS.
Diagnosis of histological chorioamnionitis and funisitis
A histological study of a placenta can be performed within 24 hours postpartum and a pathologist (MH), who was blinded to the clinical data, analysed the placentas according to the Redline criteria (20) (21) (22) . The maternal and foetal inflammatory responses were both categorised from zero for no inflammatory deviations to three for necrotising deviations with or without necrosis. The maternal inflammatory response was classified in the chorion and, or, the amnion. The first stage of the inflammation consisted of early acute subchorionitis, which is neutrophil granulocytes in the chorionic plate and, or, membranous chorion, and the second stage was acute chorioamnionitis, namely neutrophil granulocytes in the chorion and amnion. The first stage of the foetal inflammatory response was defined as umbilical phlebitis or vasculitis in the chorionic plate, which is neutrophil granulocytes in the umbilical vein and, or, chorionic vessels, and the second was umbilical arteritis, namely neutrophil granulocytes in the umbilical artery and, or, extravasation in the Wharton's jelly.
Statistical analysis All data were tested for normal distribution, using the Kolmogorov-Smirnov test and the Shapiro-Wilk test. The association between EONS and the histological inflammatory response was assessed using the chi-square test of independence. In addition, ordinal regression was used to investigate which confounders affected EONS. The Kruskall-Wallis test was used to examine whether all the children, who were divided in four groups based on EONS, had received the same dose of antibiotics. Statistical significance was defined as p < 0.05, in the univariate ordinal regression model as p < 0.10. Analyses were performed using SPSS version 22 (IBM Corp, Armonk, NY, USA).
RESULTS
Study population
In 2013, a total of 109 singleton premature neonates were born at Isala, Zwolle, The Netherlands, and 21 were excluded (Fig. 1) . The median gestational age of the 88 included infants was 30 + 0 0 (24 + 0 À 31 + 6) weeks, with a mean birth weight of 1206 AE 320 grams. No proven EONS was found in any of the 88 subjects: in 73 infants (83%), there was no suspicion of EONS, in 11 (13%) there was a low clinical suspicion and in four (4%) there was a high clinical suspicion. The baseline characteristics are given in Table 1 .
Association between EONS and a histological inflammatory response An inflammatory response was found in 15/88 placentas (17%), three showed chorioamnionitis and 12 chorioamnionitis were combined with funisitis, as shown in Table 2 . No inflammatory response was found when there was an absence of risk factors for EONS. An inflammatory response in the placenta was seen significantly more frequently in the group with a high clinical suspicion of EONS, p = 0.027 according to Fisher's exact test, than those with no or low clinical suspicion. In this highsuspicion group, all placentas showed chorioamnionitis with funisitis. There were no infants with suspicion of EONS if the placentas only showed chorioamnionitis.
Independent predictors of EONS
Ordinal regression was used to examine what other factors, besides the inflammatory response of the placenta, could predict EONS. The dependent variable was EONS, as previously defined in the four categories noted above. The predictors used in the model were as follows: gender, gestational age, birth weight, foetal heart rate, circulatory failure, mortality, total duration of hospital stay, parity, IUGR, odorous amniotic fluid, clinical suspicion of intrauterine infection, maternal temperature and the mother's age. In the univariate model IUGR (p = 0.040), mortality (p = 0.065) and adequate antibiotic prophylaxis (p = 0.057) were significant predictors. However, none of these remained significant in the multivariate model, showing that there were no independent predictors in this model.
Antibiotic treatment
In total, 75/88 infants (85%) received antibiotics, namely amoxicillin (50 mg/kg per day) and ceftazidime (50 mg/kg per day), and 37 (49%) of these received them for more than 48 hours and 19 (25%) received them for seven or more days. The median duration of antibiotic treatment for the whole group was two days (range 0-14). Table 3 shows the duration of the antibiotic treatment in relation to the histological inflammatory response. In the high-suspicion group, all infants received antibiotics for more than 48 hours and in 75% of these cases chorioamnionitis with funisitis was found. The duration of the therapy was significantly longer in the high-suspicion group than in the other two groups, according to the Kruskall-Wallis test (p = 0.000). In the no-suspicion group, 60/73 (82%) infants received antibiotic treatment during the first 48 hours and 14/73 (23%) received it for more than 48 hours, despite a serial CRP of ≤10 (mg/L). In 10 of these 14 infants (71%) treated for more than 48 hours, no histological inflammatory response was found in the placenta. In the lowsuspicion group, all 11 infants received antibiotics, with nine (82%) receiving it for more than 48 hours although none of them had signs of chorioamnionitis in the placenta.
In total, there were 202 days of antibiotic treatment in the cohort. When placental histology was used, the duration of antibiotic treatment was reduced in 20 of the 27 infants that received antibiotics for more than 48 hours (5-10 days) in cases where no chorioamnionitis and/or funisitis was present. If placental histology had been used, this would have resulted in a reduction of 100/202 (49.5%) antibiotic days.
DISCUSSION
In this pilot study, we found a significant association between suspected EONS and a histological inflammatory response in the placenta. As far as we know, our study was the first to show that placental histology can be of clinical value as an additional tool in diagnosing EONS and can facilitate medical decision-making 48 hours postpartum. Adopting this approach would reduce the duration of antibiotic treatment and decrease the use of antibiotics in the NICU. The current Dutch approach to diagnosing EONS is clinical symptoms, combined with blood culture and laboratory parameters like serial CRP. This is remarkable because placental examination is non-invasive and very informative. Placental pathology is commonly used to identify the underlying cause of an unexpected disease or death in the neonate or the pregnant woman (23) and the results of the investigation usually take several days to one week. However, this study showed that these results can probably assist the clinician at an earlier stage, within No suspicion (n = 73) Low Suspicion (n = 11) High suspicion (n = 4)
48 hours, and as such supports the value of multidisciplinary consultation between pathologists and obstetricians or neonatologists with regard to vulnerable neonatal patients. Timely reporting of placenta histology is important to realise this goal. In the last decade, much has been published about histological chorioamnionitis in relation to adverse neonatal outcomes, including bronchopulmonary dysplasia and neurodevelopmental sequelae and the association with premature birth (19, 24) . It is important to realise that acute and chronic chorioamnionitis, but also inflammation and infection, are different entities with different pathophysiological mechanisms and causes. In this study, acute infection of the placenta due to bacterial organisms such as Group B haemolytic Streptococcus or Gram-negative microorganisms such as Escherichia Coli was highlighted and scored by the Redline criteria. Grade 2 funisitis is generally considered to be evidence of a vigorous foetal response and thus a severe form of chorioamnionitis. In the third stage, full-blown chorioamnionitis develops with multiplication of microorganisms in the amniotic fluid. In the fourth foetal stage, there is a foetal infection resulting from swallowing or inhalation of microorganisms. It is important to realise that in cases of chorioamnionitis, only 3% of the neonates develop EONS proven by blood cultures (16, 17) , since most infants will be born before the third or fourth stage is reached, as was the case in 12 infants in our study. These infants received antibiotics for only 48 hours without a documented recurrent infection, suggesting the safety of stopping antibiotics after 48 hours in cases of low serial CRP and low neonatal clinical suspicion, even in the presence of chorioamnionitis. In this study, maternal and foetal responses were reported as chorioamnionitis with or without funisitis. This distinction seems useful because although the sample size was too small to draw conclusions, there was a trend towards a higher suspicion of EONS in the group with funisitis. This study also confirmed the positive predictive value of maternal risk factors (25) , such as delivery mode and maternal disease. All infants in the low-suspicion group had a normal placental histology. Most of these infants were electively born premature after a Caesarean section because of maternal obstetric complications such as HELLP syndrome or preeclampsia. Their clinical symptoms were aspecific for EONS with CRP levels >10 (mg/L) and this was most likely due to other clinical conditions, such as infant respiratory distress syndrome or transition. Placental pathology other than chorioamnionitis, such as foetal or maternal malperfusion, can further support shortening of antibiotic treatment in these infants, despite the development of aspecific clinical symptoms.
In 20 patients, our results indicated a potential shortening of antibiotic treatment from seven days to 48 hours. This trend is important because evidence of the adverse effects of prolonged antibiotic therapy is emerging. Cordero et al. (26) showed that when infants were up to 26 weeks of gestational age at the time of initial empirical therapy, and they received more than 7 days of antibiotics, they were hospitalised for longer (75 vs 59 days, p = 0.01) and spent more days on ventilators (31 vs 26 days, p = 0.05) than infants who received up to three days of antibiotics. A riskadjusted multivariable analyses by Cotton et al. showed that a prolonged period of antibiotic therapy was associated with NEC or death, with an odds ratio of 1.30 and 95% confidence interval of 1.10-1.54, and the figures for death alone were 1.46 and 1.19-1.78 (27) . Each additional day of antibiotic therapy was associated with a 4% increase in the odds of NEC or death, a 7% increase in the odds of NEC alone and a 16% increase in the odds of death alone (28) . Besides the short-term effects, the long-term effects are also becoming clearer. Decreases in the biodiversity of the microbiome, induced by antibiotics, have been linked to obesity, inflammatory bowel disease and Clostridium difficile infection (27) . In order to try to reduce the emerging development of antibiotic-resistant microorganisms, a reduction in the duration of antibiotic treatment is also very important for antibiotic stewardship on the NICU (29) .
Our study had some limitations. We conducted a retrospective study in a single-centre institution. Consequently, the sample size was relatively small, with no proven sepsis and only four infants with a high suspicion of sepsis, under powering our observations.
CONCLUSION
In our opinion, withholding empirical antibiotic treatment in premature neonates with aspecific symptoms of infection in the NICU remains difficult and excluding EONS at 48 hours is important. This study shows that this can be done by adding placental histology to the existing combination of maternal risk factors, blood cultures and CRP levels. The additional value of placental histology can probably be useful in reducing the period of empirical antibiotic treatment and contributes to antibiotic stewardship on the NICU. Large prospective studies are needed to further explore the results of this study.
